Lamyaa Al‐Riyami

1.6k total citations
34 papers, 1.3k citations indexed

About

Lamyaa Al‐Riyami is a scholar working on Parasitology, Immunology and Infectious Diseases. According to data from OpenAlex, Lamyaa Al‐Riyami has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Parasitology, 10 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Lamyaa Al‐Riyami's work include Parasites and Host Interactions (19 papers), Parasitic Diseases Research and Treatment (9 papers) and Research on Leishmaniasis Studies (6 papers). Lamyaa Al‐Riyami is often cited by papers focused on Parasites and Host Interactions (19 papers), Parasitic Diseases Research and Treatment (9 papers) and Research on Leishmaniasis Studies (6 papers). Lamyaa Al‐Riyami collaborates with scholars based in United Kingdom, United States and Australia. Lamyaa Al‐Riyami's co-authors include William Harnett, Margaret M. Harnett, Miguel A. Pineda, David T. Rodgers, Justyna Rzepecka, Katrina M. Houston, Helen S. Goodridge, Mairi McGrath, Fraser A. Marshall and Colin J. Suckling and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Scientific Reports.

In The Last Decade

Lamyaa Al‐Riyami

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lamyaa Al‐Riyami United Kingdom 19 648 340 292 216 215 34 1.3k
Marcelo Pelajo‐Machado Brazil 24 470 0.7× 264 0.8× 216 0.7× 440 2.0× 303 1.4× 79 1.6k
Farhang Alem United States 15 324 0.5× 393 1.2× 202 0.7× 80 0.4× 394 1.8× 32 1.1k
Catherine E. Lawrence United Kingdom 23 518 0.8× 572 1.7× 367 1.3× 77 0.4× 210 1.0× 38 1.6k
Minka Breloer Germany 27 525 0.8× 973 2.9× 300 1.0× 149 0.7× 669 3.1× 67 2.0k
Gary L. White United States 24 392 0.6× 238 0.7× 321 1.1× 282 1.3× 276 1.3× 70 1.5k
Tatsuya Tegoshi Japan 22 582 0.9× 506 1.5× 244 0.8× 682 3.2× 206 1.0× 63 1.7k
Antonio Ruíz Spain 25 312 0.5× 324 1.0× 101 0.3× 107 0.5× 258 1.2× 94 1.8k
A Capron France 20 530 0.8× 282 0.8× 201 0.7× 191 0.9× 140 0.7× 74 1.4k
Sasisekhar Bennuru United States 20 505 0.8× 92 0.3× 570 2.0× 113 0.5× 241 1.1× 40 1.2k
Sebastian Rausch Germany 26 856 1.3× 790 2.3× 426 1.5× 141 0.7× 804 3.7× 63 2.4k

Countries citing papers authored by Lamyaa Al‐Riyami

Since Specialization
Citations

This map shows the geographic impact of Lamyaa Al‐Riyami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamyaa Al‐Riyami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamyaa Al‐Riyami more than expected).

Fields of papers citing papers by Lamyaa Al‐Riyami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamyaa Al‐Riyami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamyaa Al‐Riyami. The network helps show where Lamyaa Al‐Riyami may publish in the future.

Co-authorship network of co-authors of Lamyaa Al‐Riyami

This figure shows the co-authorship network connecting the top 25 collaborators of Lamyaa Al‐Riyami. A scholar is included among the top collaborators of Lamyaa Al‐Riyami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamyaa Al‐Riyami. Lamyaa Al‐Riyami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doonan, James, et al.. (2024). Reduction in creatine metabolites in macrophages exposed to small molecule analogues of the anti‐inflammatory parasitic worm product ES‐62. Parasite Immunology. 46(2). e13026–e13026. 2 indexed citations
2.
Bessell, Paul R., et al.. (2020). An analysis of the impact of Newcastle disease vaccination and husbandry practice on smallholder chicken productivity in Uganda. Preventive Veterinary Medicine. 177. 104975–104975. 11 indexed citations
3.
Bessell, Paul R., et al.. (2018). Estimating the impact of administration of dewormers on smallholder chickens in Odisha State, India. Poultry Science. 98(4). 1692–1696. 4 indexed citations
4.
Al‐Riyami, Lamyaa, et al.. (2018). IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62. Scientific Reports. 8(1). 4497–4497. 176 indexed citations
5.
Bessell, Paul R., et al.. (2018). The impact of anthelmintic drugs on weight gain of smallholder goats in subtropical regions. Preventive Veterinary Medicine. 159. 72–81. 6 indexed citations
6.
Bessell, Paul R., et al.. (2017). Assessing the impact of a novel strategy for delivering animal health interventions to smallholder farmers. Preventive Veterinary Medicine. 147. 108–116. 19 indexed citations
7.
Iqbal, Asif, et al.. (2016). The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation. Journal of Biological Chemistry. 291(22). 11939–11953. 24 indexed citations
8.
Al‐Riyami, Lamyaa, Felicity E. Lumb, Graham J. Britton, et al.. (2015). The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62. Immunology Letters. 168(1). 31–40. 14 indexed citations
9.
10.
Al‐Riyami, Lamyaa, David T. Rodgers, Justyna Rzepecka, et al.. (2015). Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation. Experimental Parasitology. 158. 18–22. 9 indexed citations
11.
Aprahamian, Tamar, Xuemei Zhong, Shahzada Amir, et al.. (2015). The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model. International Journal for Parasitology. 45(4). 203–207. 41 indexed citations
12.
Rzepecka, Justyna, Lamyaa Al‐Riyami, Hwee Kee Tay, et al.. (2014). Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties. International Journal for Parasitology. 44(9). 669–674. 33 indexed citations
13.
Rzepecka, Justyna, Christina Steiger, Lamyaa Al‐Riyami, et al.. (2013). The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype. International Journal for Parasitology. 43(3-4). 211–223. 53 indexed citations
14.
Al‐Riyami, Lamyaa, Miguel A. Pineda, Justyna Rzepecka, et al.. (2013). Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis. Journal of Medicinal Chemistry. 56(24). 9982–10002. 78 indexed citations
15.
Al‐Riyami, Lamyaa & William Harnett. (2012). Immunomodulatory Properties of ES-62, a Phosphorylcholine - Containing Glycoprotein Secreted by Acanthocheilonema viteae. Endocrine Metabolic & Immune Disorders - Drug Targets. 12(1). 45–52. 31 indexed citations
16.
Pineda, Miguel A., Mairi McGrath, Lamyaa Al‐Riyami, et al.. (2012). The parasitic helminth product ES‐62 suppresses pathogenesis in collagen‐induced arthritis by targeting the interleukin‐17–producing cellular network at multiple sites. Arthritis & Rheumatism. 64(10). 3168–3178. 81 indexed citations
17.
Al‐Riyami, Lamyaa, et al.. (2011). Systemic Lupus Erythematosus with Severe Nephritis That Mimicked Henoch-Schoenlein Purpura. PubMed. 4(3). 159–61. 5 indexed citations
18.
Harnett, Margaret M., A Boitelle, Theresa Thalhamer, et al.. (2007). The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Annals of the Rheumatic Diseases. 67(4). 518–523. 77 indexed citations
19.
Goodridge, Helen S., Katrina M. Houston, Lamyaa Al‐Riyami, et al.. (2006). Phosphorylcholine mimics the effects of ES‐62 on macrophages and dendritic cells. Parasite Immunology. 29(3). 127–137. 74 indexed citations
20.
Goodridge, Helen S., Fraser A. Marshall, Kathryn J. Else, et al.. (2005). Immunomodulation via Novel Use of TLR4 by the Filarial Nematode Phosphorylcholine-Containing Secreted Product, ES-62. The Journal of Immunology. 174(1). 284–293. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo Pelajo‐Machado Breakdown of academic impact, for papers by Farhang Alem Breakdown of academic impact, for papers by Catherine E. Lawrence Breakdown of academic impact, for papers by Minka Breloer Breakdown of academic impact, for papers by Gary L. White Breakdown of academic impact, for papers by Tatsuya Tegoshi Breakdown of academic impact, for papers by Antonio Ruíz Breakdown of academic impact, for papers by A Capron Breakdown of academic impact, for papers by Sasisekhar Bennuru Breakdown of academic impact, for papers by Sebastian Rausch
Rankless by CCL
2026